Skip to content

Effectiveness of an electro-stimulator for the treatment of dry mouth in patients with Sjogren's syndrome

Long-term effectiveness of a novel intra-oral electro-stimulator for the treatment of dry mouth in patients with Sjogren's syndrome: a feasibility study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN58887461
Enrollment
30
Registered
2012-07-30
Start date
2012-03-01
Completion date
Unknown
Last updated
2020-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral, gastrointestinal and dental Digestive System Dry mouth, unspecified

Interventions

Electrostimulation, Intra-oral electrostimulating device (salivary pacemaker)

Sponsors

University College London Hospitals NHS Foundation Trust (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Be at least 18 years of age 2. Have clinical symptoms of xerostomia (dry mouth) due to primary SS syndrome diagnosed on the basis of 2001 EUUSA classification criteria 3. Degree of dry mouth symptoms: a minimum degree of dryness of 50mm (=50mm) on a 100mm VAS scale (0= no dryness; 100 = maximum dryness) 4. NO systemic sialogogue therapy (e.g. pilocarpine) for the duration of the study 5. Female patients of child bearing potential must have a negative pregnancy test within twenty-four hours of enrolment 6. To understand and consent in writing to the procedure 7. To agree to undergo all the examinations and clinical evaluations of the study 8. To have evidence of residual salivary gland function, by demonstrating an increase in salivary flow on appropriate stimulation e.g. citric acid stimulation or chewing paraffin wax) 9. To have unstimulated whole salivary flow higher than 0 ml/15min (unstimulated salivary flow as measured via sialometry for 15 minutes) 10. Male and female particioants

Exclusion criteria

Exclusion criteria: 1. Severe systemic disease (on the basis of the classification of the American Society of Anesthesiology: ASAIII and ASA IV) 2. Known allergy to materials similar to those used in the investigational product 3. To wear other active implants such as cardiac pacemaker or defibrillator, or hearing aids 4. Complete lower edentulous status (i.e. possess no lower teeth) 5. To have oral anatomical or disease-related characteristics that preclude the insertion of the device (e.g. mandibular torus, severe trismus) 6. To be unable or unwilling to cooperate with study procedures 7. To have evidence of no residual salivary gland function (via citric acid stimulation or chewing paraffin wax test) 8. To have an unstimulated whole salivary flow = 0 ml/15min (Absence of unstimulated salivary flow as measured via sialometry for 15 minutes)

Design outcomes

Primary

MeasureTime frame
Reduction in dry mouth symptoms measured at 1, 2, 4, 5 months

Secondary

MeasureTime frame
No secondary outcome measures

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026